Neurosyphilis is increasing due to a rise in the number of cases of sy
philis in cocaine/crack addicts and in patients with HIV infection. Ne
urosyphilis is an example of a unique group of chronic CNS diseases th
at may cause either a degenerative or a vasculitic process, where the
main pathogenic event is 'end-arteritis obliterans' of terminal arteri
oles. In meningovascular neurosyphilis, the most commonly involved art
ery is the middle cerebral artery. It generally presents with a prodro
mic phase, weeks or months before the onset of identifiable vascular s
yndromes. When there is focal inflammation the clinical picture is cha
racterized by hemiplegia, whereas in the case of multifocal involvemen
t of small intracranial arteries, it presents with a slowly progressiv
e loss of cognitive functioning and personality changes. Since neurolo
gical deficits once established may only slightly improve with treatme
nt, the goal of therapy is to halt the progression of the disease. Int
ravenous aqueous crystallin penicillin G is the most accepted treatmen
t. HIV-infected patients have shown accelerated development of neurosy
philis, and it is suggested that coinfection with HIV alters the cours
e of Treponema pallidum infection. Atypical manifestations of neurosyp
hilis have been reported among HIV patients, including fulminant prese
ntation, rapid progression, atypical serological findings, and failure
of conventional doses of penicillin to eradicate infection.